Clinical trial
APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID)…
NCT00095368 · Advancis Pharmaceutical Corporation, Industry · Completed
Key facts
| NCT number | NCT00095368 |
|---|---|
| Title | APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat |
| Official title | A Phase III, Randomized, Double-Blind, Double-Dummy Multicenter Study to Evaluate the Efficacy and Safety of 775 mg APC-111 MP Tablet QD for 7 Days vs Penicillin VK 250 mg QID for 10 Days in Patients With Streptococcus Pyogenes |
| Lead sponsor | Advancis Pharmaceutical Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pharyngitis, Tonsillitis |
| Intervention type | Drug |
| Interventions | Amoxicillin Pulsatile Release Multiparticulate Tablet (drug) |
| Enrollment | 500 |
| Start date | Oct 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Nov 4, 2004 |
| Last update posted | Dec 8, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: